Podcasts about msd

How do you actually pick which heifers to keep? For many, selecting the top ones is easy, but it's those middle ones that are hard to choose between. For this week's guest, Geoff Hayes, the answer is genomics. Geoff and his wife Belinda started their Angus stud just 5 years ago, but began their genomic journey early, not wanting to pick bulls on looks alone from the very beginning. "I was hesitant just to go and pick them visually," Geoff explains. "We need to put some science into it."They began with a base genomic test across a random selection of purchased cattle, which showed them that they were fine for IMF, but needed to increase ribeye area, and that became the main basis of their early selection focus.Over time, that focus shifted. Rather than just chasing carcass traits, they started looking for sires out of cow families with longevity in the background. This introduced more of a focus on the maternal and stayability traits. Geoff still tests his own weaners before deciding which ones to keep and that same mindset is now extending to heifers, with Geoff part of MLA's heifer PDS project. The project involves genotyping heifers, alongside visual measurements to help guide replacement decisions. This project is ongoing, and we will have results to share in the coming years. Mark and Geoff finish by talking about where the beef industry is headed with record property and beef values, as well as the possibilities of new technology just around the corner.Optimised Heifer Selection is a Producer Demonstration Site (PDS) project funded by Meat & Livestock Australia and facilitated by neXtgen Agri. Geoff Hayes is a core producer demonstration site for this project. If you would like to learn more about this PDS project, you can visit the Heifer Selection Hub page or contact: Georgia Pugh, neXtgen Agri M: +61 408 947 488 E: georgia@nextgenagri.comHead Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

Pete Fennessy has spent more than fifty years involved in science, genetics and livestock production, helping shape many of the ideas that transformed New Zealand's sheep and deer industries. Pete spent two decades at Invermay before becoming General Manager of AgResearch's Sheep, Deer and Equine Division, later founding AbacusBio alongside a group of colleagues and helping build it into an internationally recognised consultancy. More recently, his focus has turned to new challenges facing NZ agriculture, including methane, meat and the future direction of livestock production.In this episode, Pete chats with Mark about the people, ideas and turning points that drove decades of productivity gains. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

Author of the “Things that Make You Go Hmmm” newsletter, Grant Williams, rejoins the MSD airwaves for this week's long-form episode. The conversation provides a bit of a twist not typical of MSD. Instead of mostly speaking of metals, commodities and markets, Trevor and Grant stroll down the path of sport. The World Cup has grabbed the attention of a global audience. But the bylines within the tournament itself allow Trevor and Grant to explore how the tournament is more symbolic of current-day society, markets and culture. ______Terrahutton empowers junior mining companies to secure investment with immersive, interactive, and visually striking storytelling. Learn more about the Terrahutton platform ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠______This episode of Mining Stock Daily is brought to you by... ⁠⁠⁠⁠⁠⁠⁠⁠⁠Revival Gold ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vizsla Silver⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Equinox Gold⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Integra Resources ⁠⁠⁠⁠⁠⁠⁠⁠⁠

Yukon Metals CEO Jim Coates joins MSD to discuss the company's newly staked Tummel tungsten project, expanding a Yukon critical-metals portfolio that already includes Risby and Clea. Coates explains Tummel's Union Carbide history, high-grade tungsten showings, and the broader strategic interest in non-Chinese tungsten supply. He also updates drilling at the AZ and Birch copper-gold targets, where roughly 5,000 meters have been completed or are underway. With fresh financing closed, Yukon Metals is preparing mid-summer assay and geophysical news flow.

Sam Spring of Kincora Copper joined MSD from the Rule Symposium to discuss the company's divestment away from Mongolia and being 100% focused on project generation in Australia. Sam also provides insights into the current portfolio of projects and their two priority projects driving exploration.

Ian Harris, CEO of Copper Giant Resources, joins MSD from Boca Raton for an introduction into the company and its exploration work at the Mocoa project in Colombia. Ian shines light into the geology of the project and why Colombia is seeing a resurgence of exploration and mining capital following the country's recent presidential election.

This episode covers: Cardiology This Week: A concise summary of recent studies AI & digital solutions in emergency medicine Management of heart failure in cardiac amyloidosis Spotlight: Orthodexia-Platypnoea Syndrome Host: Emer Joyce Guests: Marianna Fontana, Wolf Hautz, Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2551 Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: https://esc365.escardio.org/event/2551?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Wolf Hautz and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.  Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Emer Joyce Guests: Marianna Fontana Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: https://esc365.escardio.org/event/2551?resource=interview Want to watch that episode? Go to: https://esc365.escardio.org/event/2551   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Executive Chairman of Hemlo Mining, Jonathan Awde, joined MSD from the Rule Investment Symposium this week to discuss the acquisition of the Hemlo Mine last year and the opportunities the team sees for expanding the mine. The company is embarking on a massive drill program with a technical report expected in 2027 which would highlight the mine plan optionality for the operation.

John Black returns to MSD for an Aldebaran explorartion update from their Altar Project. Camp has recently been closed for the season, but the company did complete a fresh round of infill driling for PFS-level conversion. John also walks through the latest updates on the Centauri Metals spinout, which is anticipated to finalize this fall.

Jason Jessup, CEO of Magna Mining, joins MSD from the Rule Investment Symposium to walk listeners through the new C$140M financing from Alpayana. The strategic investment creates a new 19.9% shareholder of the company. Jason walks us through the synergies of the companies and how the deal came together. Jason also provides insights into the latest drill results from the Levack Mine's R2 Footwall zone and the latest mine rates at McCreedy West.

Kenorland Minerals CEO, Zach Flood, joins MSD from the Rule Investment Symposium for a thorough exploration update on the company's portfolio of assets. Much of the discussion centers on the latest work and developments from the South Uchi gold project with partners, Auranova Resources, which is set to see a follow-up drill program in Q3.

This week on the podcast we have Joshua Barton chatting to Mark about the benefits of precision sheep management and the results it can get you. Josh is currently stockman at Hillcroft Farms and recently shared some great scanning results with us as the outcome of well-planned precision lambing. Josh shares these results as well as discussing how Hillcroft's ultra-white breeding program has evolved.Josh and Mark also cover the HF Plus gene and what it is doing for fertility and why better data is the only way forward if you want to increase your production. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

Erica Stanford on boosting language skills before school; Homeless Aucklanders respond to emergency housing targets; MSD chief responds to criticism of housing targets; Meridian CEO Mike Roan speaks to John Campbell; Review finds widespread failures in government tech; All Black Fletcher Newell speaks to John Campbell

It's time for our Politics Panel and this week Nick Mills is joined by Labour MP Ayesha Verrall and National MP for Otaki Tim Costley. Starting with Minister Casey Costello's statement that she is considering a review on excise tax of tobacco. We hear what Verrall and Costley think of this stance and how do we address the growth of the illicit tobacco trade. The death of a man who spent 9 hours in the Waikato Hospital Emergency Department has bought attention to ED wait times. How are the politicians working to stop this tragedy from ever happening again? And the big reveal earlier in the week that MSD had a metric for staff of emergency housing numbers, potentially incentivising staff to deny the support. Plus, the panel discuss regulating politicians on social media. LISTEN ABOVESee omnystudio.com/listener for privacy information.

A GP and public health expert says ACT's welfare policy assumes people on health and disability benefits are getting them too easily. The party is campaigning on a welfare clamp down, and wants to make it mandatory for all health and disability benefits to be issued by MSD approved, designated doctors. Clinical director of the National Hauora Coalition, Dr Nina Bevin spoke to Lisa Owen.

Rt Hon CHRIS HIPKINS to the Prime Minister: Does he stand by all his statements and actions? LAURA McCLURE to the Associate Minister of Education: What recent reports has he seen on school attendance? CHLÖE SWARBRICK to the Prime Minister: E tautoko ana ia i nga korero me nga mahi katoa a tona Kawanatanga? Does he stand by all of his Government's statements and actions? RYAN HAMILTON to the Minister of Finance: How is the Government planning to lift economic growth and productivity? Hon BARBARA EDMONDS to the Minister of Finance: Does she stand by all her statements and actions? GRANT McCALLUM to the Minister for Infrastructure: What updates has he seen on the fast-track approvals scheme? Hon MARAMA DAVIDSON to the Prime Minister: E tautoko ana ia i nga korero me nga mahi katoa a tona Kawanatanga? Does he stand by all of his Government's statements and actions? Hon KIERAN McANULTY to the Associate Minister of Housing: Does he stand by his response to being asked if he was comfortable with managers being individually assessed on whether or not emergency housing targets were met in their region, "No. That would be something that I'd ask the chief executive at MSD about"; if so, has he had this conversation? MARIAMENO KAPA-KINGI to the Associate Minister of Housing: Does he agree with the Ministry of Social Development's use of performance measures that assess managers against emergency housing grant targets? KATIE NIMON to the Minister of Health: What recent announcement has he made regarding funding uplifts for primary and community services? SHANAN HALBERT to the Minister for Tertiary Education: Does she stand by her statement, "Having the confidence to build and strengthen your team is important, especially when many businesses are doing it tough right now"; if so, why did she limit Apprenticeship Boost? SUZE REDMAYNE to the Minister of Agriculture: What recent reports has he seen on the forecast for New Zealand's food and fibre exports?

ACT is campaigning on a welfare clampdown this election, saying benefits should be a hand up not a way of life. It wants to be make it mandatory for all health and disability benefits to be issued by MSD approved, designated doctors. Beneficiary advocate Kay Brereton says the policy shows a complete lack of understand of some peoples reality. Brereton spoke to Lisa Owen.

How do Australian and New Zealand farmers stay competitive when the rest of the world is changing faster than ever?For our guest this week, Richard Green, it starts by accepting that yesterday's thinking will not solve tomorrow's problems."It frustrates the hell out of me when I hear us talk about 'We're the best farmers in the world.'" explains Richard. "And we may have been, but that's a moment in time. There's so much change, progress and disruption happening around the world. We're only as good as how we were yesterday, and every day we've got to improve."Richard's recent travels gave him new insight into where the world and the red meat sector are going. He explains the concept of a hybrid consumer where some people are shopping for experiences and absolute luxury... And then there are the "normal" people who shop at the value end who still want quality, but want as much value within that as possible. And, as Richard explains, the "middle" has been completely hollowed out. "Commit to volume and efficiency, or commit to a genuine premium value proposition. Half-measures won't cut it." explains Richard. "If you're competing on a commodity, compete hard and be exceptional at it. If you're not, build a differentiated supply chain with genuine partners - offshore, in-market, and at the processing end."He explains how the South American commodity powerhouses have been doing it well, by scaling their surpluses into global supply chains and manufacturing, and how we could take some lessons from them. Mark and Richard also cover Cultivate Ventures, the growth fund Richard chairs. Born partly from a goal he set himself, Richard realised money made in the industry wasn't going to flow to the farmers, it was going to flow to where the capital returns- aka the investors.. So they decided they had to invest in these disruptive businesses to ensure farmers got their share of the success. They finish the conversation discussing the relationship between physical challenge and business mindset. Richard is no stranger to an intense physical challenge. He has run the Kepler, one of New Zealand's great walks (that usually takes 3 days) in a day, and ridden the length of both islands by bike."If I'm challenging myself physically, it helps me be more positive about life..." he explains. "It just realises that you are as an individual capable of a lot more, and if you realise that, then it helps you drive your businesses to be capable of a lot more too."Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

This episode covers: Cardiology This Week: A concise summary of recent studies Host: Emer Joyce Guests: Yasmina Bououdina, JP Carpenter, Milton Packer, Lorenz Raeber Want to watch that episode? Go to: https://esc365.escardio.org/event/2558 Want to watch that extended interview on PCI guidance by intracoronary imaging, go to: https://esc365.escardio.org/event/2558?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Milton Packer has declared to have potential conflicts of interest to report: 89bio, Abbvie, Actavis, Altimmune, Alnylam, Amarin, Amgen, Ardelyx, ARMGO, AstraZeneca, Attralus, Biopeutics, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Daiichi Sankyo, Imara, Lilly, Medtronic, Moderna, Novartis, NovoNordisk, Pharmacocosmos, Regeneron, Roche, Salamandra. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Emer Joyce Guest: Lorenz Raeber Want to watch that extended interview on https://esc365.escardio.org/event/2558?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2558   Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Long before performance recording became mainstream, George Fell's grandfather was building a sheep breeding programme around growth, efficiency and measured performance on pasture. Unable to find the genetics he wanted, he created them himself.Today, that same mindset runs through everything at Fell's Yorkshire farming business. Alongside the MeatLink sheep breeding programme, the family operates a diverse farming enterprise that includes Premier League-level turf production, free-range eggs and dairy beef finishing.In this episode, George joins Mark to discuss the origins of the MeatLink breed, the role performance recording has played in its development, and the current state of the UK sheep industry. They also discuss how a sheep breeding business evolved into one of the UK's leading turf producers and why the same principles of performance and continuous improvement underpin both enterprises.George is also Chair of the Sheep Breeders Round Table and discusses this year's conference, where Mark will be a guest speaker.UK Sheep Breeders Roundtable Conference 2026Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

The Social Development Minister's standing by her changes to the welfare system. Louise Upston wants to slash the number of people on Jobseeker to 140 thousand by 2030. Labour claims they're on track to miss the target by more than 60 thousand people and their current approach isn't creating the right conditions to help people into work. But Upston told Mike Hosking she's serious about every single person on Jobseeker. She says MSD is more proactive in working with employers and job seekers and making important matches to get people into work. LISTEN ABOVE See omnystudio.com/listener for privacy information.

What does a cow actually cost to run?At Kerin Ag, every kilogram of utilisable feed has a value attached to it. That allows Joe Kerin and the team to measure whether an animal is genuinely paying its way.In this episode, Joe joins Mark to discuss how putting a dollar value on each kilogram of grass they grow led them to choose Wagyu over Angus. As any Kerin would, Joe has done the numbers and compared Wagyu cows with larger recipient cows, based on the weaning weight of their calves relative to the kg of dry matter consumed by the cows. And, as predicted, the moderate-sized cow is far more efficient than the larger Angus X recipients. Joe also discusses the role of genomics in Wagyu breeding. As they are a breed with a very narrow gene pool and are bred for carcass-related attributes, genomics is incredibly important, and Joe utilises it to its fullest.Tune in to learn how to turn grass into money - this time with cattle.Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

This episode covers: Cardiology This Week: A concise summary of recent studies Transcatheter treatment of tricuspid regurgitation Carcinoid heart disease Milestones: MADIT-II Trial Host: Wilfried Mullens Guests: Stephan Baldus, Heidi Connolly and Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2560 Want to watch that extended interview on transcatheter treatment of tricuspid regurgitation, go to: https://esc365.escardio.org/event/2560?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Heidi Connolly, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Wilfried Mullens Guest: Stephan Baldus Want to watch that extended interview, go to: https://esc365.escardio.org/event/2560?resource=interview Want to watch that entire episode? Go to: https://esc365.escardio.org/event/2560   Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Few people have had a front-row seat to the genetic improvement of New Zealand sheep quite like our guest this week, Simon Buckley.After growing up in Whangārei and starting his farming career at Castlepoint Station, Simon joined Wairere Romneys and has never left. Four decades later, he has helped one of New Zealand's most influential sheep breeding programmes through the transition from visual selection and paper records to EID, genomics and data-driven breeding.In this episode, Simon chats with Mark to discuss the history of Wairere and the long-term thinking required to make meaningful genetic progress. They also discuss maternal instinct, breeding sheep for commercial conditions, the challenge of balancing innovation with market demand, and the lessons he's learnt from those who have travelled through the "University of Wairere".Grab a coffee and sit back and enjoy this one - it's a goodie! Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

On this week's episode, the guys test whether artificial intelligence can replace a person - with AI‑cloned "Josh" sprinkled through the episode. Chris and Mark cover the rapid early success of Apple's new MacBook Neo, including Kansas City Public Schools' plan to replace roughly 30,000 Windows PCs and Chromebooks after a 4,500‑unit proof of concept. Elizabethtown Area School District's cell phone and smartwatch ban (and the community reaction to program names like “Cellcatraz” versus “Device Den”) is discussed. The guys highlight new guidance from the National Council of Teachers of English on using AI in ELA classrooms, centered on a practical stoplight model (red, yellow, green) that helps teachers define AI use. A major segment revisits last week's episode about showing movies in class. Finally, Chris interviews Chantell Manahan, Director of Technology at MSD of Steuben County, to discuss her district's experience with SysCloud. Join us July 6th-10th, 2026 – GAMEIS Conference in Savannah, GA Join us at MidwestTechTalk ———— Sponsored by: SysCloud Meter Fortinet Managed Methods NetWatch   Today's K-12 schools are balancing more than ever, student safety, campus communication, cybersecurity, and growing technology demands. For more than 20 years, NetWatch has partnered with schools to help create safer and smarter learning environments through integrated technology and security solutions. From AI-powered video surveillance and access control to emergency communications and IP paging systems, structured cabling, and managed IT services, our team helps keep your campuses SAFE, SECURE, and CONNECTED. As an Axis Communications Gold Solution Partner, NetWatch delivers industry-leading security technology backed by trusted expertise and long-term support for your district. Whether you're planning infrastructure upgrades, improving campus security, or preparing for future technology needs, NetWatch is here to help. Ready to strengthen your campus technology and security strategy? Visit NetWatchIP.com and connect with our team today. NetWatch, Protect and Connect with Confidence. ———— Join the K12TechPro Community (exclusively for K12 Tech professionals) Buy some swag (tech dept gift boxes, shirts, hoodies...)!!! Email us at k12techtalk@gmail.com OR our "professional" email addy is info@k12techtalkpodcast.com X @k12techtalkpod Facebook Visit our LinkedIn Music by Colt Ball Disclaimer: The views and work done by Josh, Chris, and Mark are solely their own and do not reflect the opinions or positions of sponsors or any respective employers or organizations associated with the guys. K12 Tech Talk itself does not endorse or validate the ideas, views, or statements expressed by Josh, Chris, and Mark's individual views and opinions are not representative of K12 Tech Talk. Furthermore, any references or mention of products, services, organizations, or individuals on K12 Tech Talk should not be considered as endorsements related to any employer or organization associated with the guys.

We have a lot of new drill results out this morning. MSD covers the latest from Cabral Gold, Q2 Metals, GreenLight Metals and Scorpio Gold today. Central Asia Metals has announced a proposed all-share acquisition of Cygnus Metals valued at approximately A$232 million. Newcore Gold has increased its 2026 drill program at the Enchi Gold Project in Ghana to 80,000 metres. Integra Resources has appointed Ausenco Engineering USA South as lead partner for detailed engineering at the DeLamar Gold-Silver Project.This episode of Mining Stock Daily is brought to you by... ⁠⁠⁠⁠⁠⁠Revival Gold ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vizsla Silver⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Equinox Gold⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Integra Resources ⁠⁠⁠⁠⁠⁠

Tocvan Ventures' Chris Gordon joins MSD to update exploration and development work at the Gran Pilar gold-silver project in Sonora, Mexico. The company is 6,000 meters into a planned 20,000-meter drill program and has identified new mineralized zones away from the main deposit, including El Mesquite and other South Block targets. Tocvan is also advancing its pilot mine, with infrastructure underway, processing equipment expected soon, and first processing targeted for October. Gordon says upcoming catalysts include drilling, pilot production, permitting, and a maiden resource estimate.

MSD's Ian Wagner speaks with Jonathan Egilo of Axo Metals about the company's shift from copper exploration toward near-term gold development in Mexico. Egilo details Axo's acquisition of the San Antonio gold project, a partly built heap-leach asset with a 1.1-million-ounce resource and a high-grade oxide starter pit. He also discusses the La Huerta copper project, ongoing drilling, permitting work, and the company's build-to-operate strategy as Axo looks to advance San Antonio toward production and cash flow.

MSD's Ian Wagner speaks with Latin Metals CEO Keith Henderson at Deutsche Gold Messe in Frankfurt. Henderson outlines the company's prospect-generator model, which prioritizes asset-level dilution over shareholder dilution by bringing in partners to fund high-risk exploration. Latin Metals is focused on Argentina and Peru, with projects spanning copper, gold and broader base-metal opportunities. Henderson highlights the company's 500,000-hectare sediment-hosted copper play in Argentina and the Organullo porphyry project, where Moxico is funding major drilling and studies. Latin Metals trades as LMS on the TSX-V and LMSQF on the OTCQB.

This episode covers: Cardiology This Week: A concise summary of recent studies The heart in high altitude Mitral annular disjunction Mythbusters: Weekend mortality Host: Rick Grobbee Guests: JP Carpenter, Kristina Haugaa, Silvia Ulrich Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Want to watch that extended interview on mitral annular disjonction, go to: https://esc365.escardio.org/event/2563?resource=interview   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Silvia Ulrich have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Rick Grobbee Guest: Kristina Haugaa Want to watch that extended interview on https://esc365.escardio.org/event/2563?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2563   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

MSD's Ian Wagner speaks with Sean Howarth of Excellon Resources at Deutsche Goldmesse in Frankfurt. Howarth outlines Excellon's renewed focus on Peru, where the company is advancing the past-producing Mallay silver mine toward restart while drilling to extend resources and test parallel zones. He also discusses the nearby Tres Cerros target, an undrilled gold-silver opportunity, along with Excellon's Kilgore gold project in Idaho and German silver assets. The strategy centers on near-term cash flow, resource growth, and silver leverage. Excellon trades on the TSX-V under EXN. 

MSD's Ian Wagner speaks with Kingfisher Metals President and CEO Dustin Perry at Deutsche Goldmesse in Frankfurt. Perry outlines Kingfisher's large Golden Triangle land package in British Columbia, where the company is following up a new copper-gold porphyry discovery at Williams and advancing the Hank epithermal system. With about $30 million in the bank, Kingfisher plans roughly 15,000 meters of drilling, plus regional geophysics across its district-scale holdings. Perry says the goal is to prove scale, continuity, and higher-grade zones. Kingfisher trades on the TSX-V under KFR. 

Talisker Resources CEO Terry Harbort joins MSD's Ian Wagner discusses the company's updated resource at the Bralorne Gold Project in British Columbia, which now totals nearly 3.4 million ounces across measured, indicated, and inferred categories. The update more than doubles the global resource and highlights high-grade material at Mustang and Olympus. Talisker is also advancing a 105,000-meter drill program focused largely on resource conversion, while ramping production at Mustang. Ore sorting, expanded trucking rates, and a coming PEA are key milestones for 2026.

The chaos starts EARLY on this daily comedy show when Rafe wakes up convinced the evil clown from Poltergeist finally came for him… only to discover his blind dog Bo trapped underneath the bed like a furry little cryptid with no exit strategy. Naturally, instead of calmly handling the situation like adults, the show spirals immediately into discussions about utility companies rescuing animals, tow truck conspiracies, and whether MSD has a secret deer extraction task force. You know… journalism.Then the crew dives headfirst into the truly important national debate: what is ACTUALLY the best day of a three-day weekend? Is it the first Saturday because there are “no consequences”? Is Sunday secretly elite because Monday still exists? Or is Monday only enjoyable if you're some kind of psychopath who enjoys thinking about Tuesday? The answers get oddly passionate for a group of people operating on gas station coffee and sarcasm.Meanwhile, competitive eating legend Joey Chestnut returns to the spotlight with legal drama attached to his mustard belt. Joey apparently pleaded guilty to slapping a guy during a bar altercation, which somehow becomes less shocking once the crew starts imagining him assaulting someone with a hot dog. The gang also reacts to Joey setting a NEW world record by consuming 16 pounds of bologna in eight minutes — which is either athletic greatness or a cry for help. Maybe both.The episode somehow gets even weirder with conversations about AI juries replacing humans, Britney Spears offering cops homemade lasagna during a DUI stop, wisdom teeth horror stories, nitrous gas adventures, and King Scott accidentally discovering that tow truck companies can basically repossess your soul after 45 days. Honestly, if anxiety had a group project, it would sound exactly like this episode.Also included:Blind dog rescue operations at 1:30amWhy no one trusts AI to judge crimesThe economics of pontoon weekendsWhy Brittany Spears' lasagna probably crunchesTow truck companies apparently becoming landlords nowWisdom tooth extraction traumaAnalog people vs AI peopleWet t-shirt contest discussions because this is still radio somehowThis daily comedy show delivers peak Rizzuto Show energy: chaotic conversations, sarcastic takes, wildly unnecessary debates, and the kind of ridiculous storytelling that makes you feel better about your own life choices.And yes… somebody absolutely says “Department of Ho Land Security.”Because of course they do.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShowHear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.Michigan tenant who called landlord to work on home catches him on camera having sex insideAlachua County woman accused of throwing feces at father during fightJoey Chestnut pleads guilty after bar fight — here's what it will mean for July 4 Nathan's competitionBritney Spears Spoke ‘Nonsensically' During D.U.I. Arrest, Records SaySchlitz beer stops brewing after historic 175-year run in MilwaukeeFriday FailsMasked NJ suspect charged with using fuel, fireworks in Walmart kids section as cover for massive jewelry heistNew York man arrested for driving drunk to pick up friend after DWI arrest: sheriffFlorida woman arrested after golf course joyride fueled by 21(!) mini bottles of FireballIndiana man seen dancing in roadway while cradling rare turtle arrested for meth possessionIt's sugar: Florida man blows fentanyl in deputy's face, sheriff's office saysWoman arrested after Hillsborough Co. deputies chase stolen Red Bull truck across multiple countiesThree Ardmore men arrested, accused of stealing bongs in gas station burglaryMan booked after allegedly stealing ‘O' from Tacoma Police sign, damaging front gateWoman Charged With Smuggling After Shoving Wine Bottle in Her ‘Body Cavity'See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Bei der Abstimmung über die neuen Verträge mit der EU soll es das Mehr von Volk und Ständen brauchen. Das hat heute auf die Staatspolitische Kommission des Ständerats entschieden. Und weil es um viel geht, wird im Bundeshaus inzwischen sogar darüber gestritten, welche Kommission zuständig ist. Alle Themen: (00:00) Intro und Schlagzeilen (01:14) Streit im Bundeshaus um Ständemehr (06:23) Nachrichtenübersicht (10:49) Der neue NDB-Chef krempelt den Geheimdienst um (15:31) Nato: Entfremdung zwischen USA und Europa nimmt zu (18:55) Proteste gegen Treffen der Sudetendeutschen (23:44) Die Grünen wählen Greta Gysin zur Fraktionschefin (28:44) Bilanz der Personenfreizügigkeit (36:05) MSD, der wenig bekannte Pharmariese

Sirios Resources CEO Jean-Félix Lepage joins MSD's Ian Wagner in Frankfurt to discuss the Cheechoo gold project in Quebec's James Bay region. Lepage outlines the project's nearly three-million-ounce resource, including an open-pit component grading above one gram per tonne with a low strip ratio. He also discusses the company's recent financing, a planned 25,000-meter summer drill program, a resource update expected before year-end, and a PEA targeted for the first half of next year. Sirios trades on the TSX-V under SOI. 

Amarc Resources CEO Dr. Diane Nicolson joins MSD's Ian Wagner in Frankfurt to discuss the company's three copper-gold porphyry districts in British Columbia: Joy, Duke, and Ike. Nicolson highlights the Aurora discovery at Joy, describing it as a near-surface, high-grade gold-enriched copper porphyry that could help unlock the broader district. She also discusses Freeport's continued funding at Joy, Boliden's partnership at Duke, and the company's broader strategy as a discoverer, developer, and transactor of major copper-gold systems.

Hayasa Metals CEO Joel Sutherland joins MSD's Ian Wagner in Frankfurt to discuss the company's gold and copper exploration strategy in Armenia. Sutherland outlines the broader Armenia thesis, pointing to underexplored geology in the Tethyan Belt, improving Western engagement, and growing interest in critical minerals. He also discusses Hayasa's partnership with Teck at the Vardenis copper-molybdenum project, ongoing work at Urasar, and plans to add three new properties this year. Hayasa trades on the TSX-V under HAY and Frankfurt under FR20. 

Today's episode of The Rizzuto Show turns into a full-on wilderness survival documentary… except nobody survives with dignity intact.The gang kicks things off talking about King Scott's rain-soaked blood drive experience, complete with lightning, wet parking lots, and accusations that his blood immediately got thrown in the trash because “ginger blood isn't FDA approved.” Real teamwork stuff. Then things somehow pivot into a full review of the St. Louis Aquarium, where Rafe realizes he's accidentally been recommending what may actually be a third-grade field trip destination to every adult tourist he's met for the last five years.Apparently, for the low low price of fifty bucks, you too can enjoy seven mirrors, stressed-out otters doing all the heavy lifting, and a ropes course so terrifying it nearly destroyed an entire family emotionally in real time. Nothing says “fun day in St. Louis” like watching a dad's cargo shorts lose a battle against gravity while suspended from the rafters of Union Station.But the true centerpiece of this daily comedy show is Riz's attempted baby deer rescue.A tiny fawn gets trapped inside an MSD fenced enclosure behind his house during a storm, and what begins as a heroic wildlife rescue instantly devolves into one of the funniest group-chat pile-ons in show history. Riz insists he “did everything he could,” while everyone else points out that his version of heroism mostly involved making phone calls, avoiding mud, refusing to climb a fence, and eventually taking a nap while the deer repeatedly knocked itself unconscious.Meanwhile, Moon keeps demanding bolt cutters, Lern is ready to climb barbed wire with a quilt like it's 1987, and Rafe essentially puts Riz on trial for crimes against masculinity. Somehow, despite all odds, the deer survives thanks to the ACTUAL heroes: two MSD workers who show up with keys while Riz continues defending his life choices from the warmth of indoors.Also in this episode:Why St. Louis weather feels personally offensive nowThe aquarium train ride narrated by a wildly underutilized John GoodmanWhy ropes courses are apparently medieval torture devicesThe ethics of touching wild animalsFinal week of school energyAnother kid crawling into a claw machineWhy everyone immediately turned on Riz in the group chatAnd the growing realization that “calling someone else” may actually be Riz's superpowerThis daily comedy show somehow combines wildlife rescue failure, aquarium disappointment, family trauma, weather rage, and public humiliation into one beautifully chaotic morning.Honestly? The baby deer may recover faster than Riz's reputation.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShow.Hear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cartier Resources CEO Philippe Cloutier joins MSD's Ian Wagner in Frankfurt to discuss the company's Cadillac gold project in Québec's Abitibi region. Cloutier highlights recent metallurgical test work showing gold recoveries near 97%, improving on historic assumptions and strengthening the case for a new economic assessment. He also discusses Cartier's 3.2-million-ounce resource, a 100,000-meter drill program, new discoveries along the Cadillac trend, and strategic options ranging from toll milling and staged development to joint ventures or M&A along with the company's new U-S listing.

What does truly integrated care look like in practice? Host Matt Crespin captured the conversations at ADHA's first-ever Integrated Care Summit in Broomfield, Colorado this past weekend — bringing together physicians, dentists, periodontists, and public health professionals making the case for breaking down silos. (1:56) Dr. Mychi Nguyen, Chief Medical Officer at Asian Health Services, shares how a patient's powerful words — "How can I be healthy if I don't have teeth?" — launched a dental clinic at her FQHC and explains the AHA's Healthy Smiles, Healthy Hearts initiative transforming dental visits into preventive health opportunities. (8:48) AGD President-elect George J. Schmidt reflects on the growing ADHA-AGD collaboration. (15:19) Dr. Elizabeth Ramos of the American Academy of Periodontology makes the case for hygienists as key communicators of the perio-systemic connection. (24:08) Michael Lazzara, VP of International Business Development of Dento, introduces oral health biomarker testing that gives patients real-time data to motivate behavior change. And (35:37) Holly Kingsbury of the Colorado Community Health Network walks through a promising model for integrating behavioral health screenings into dental visits at FQHCs statewide.Guests: Mychi Nguyen, MD; George J. Schmidt, DMD, FAGD, FICOI; Elizabeth D. Ramos, DDS, MSD, EdD; Michael Lazzara, Dento; Holly Kingsbury, MPHHost: Matt Crespin, MPH, RDH, FADHA

Bonterra Resources Chairman Cesar Gonzalez joins MSD's Ian Wagner to discuss a busy period for the Abitibi gold developer, including Marc-Andre Pelletier's departure as CEO and Gonzalez stepping in as interim CEO. Gonzalez reviews progress on the Gold Fields joint venture at Barry, where deep drilling has wrapped up and assay results are being prepared. He also outlines work on a Barry PEA and a 10,000-to-12,000-meter drill program at the company's 100%-owned Bachelor-Moroy and Desmaraisville assets, where Bonterra is testing regional and deep feeder-zone targets.

MSD's Ian Wagner reconnects with Blue Moon Metals CEO Christian Kargl-Simard to discuss the company's rapid evolution following a C$156 million financing. Kargl-Simard outlines how Blue Moon plans to fund and sequence multiple assets, including the Nussir copper project in Norway, the Springer tungsten restart in Nevada, and the Blue Moon zinc project in California. He also discusses potential strategic capital for tungsten and APT production, growing U.S. investor interest, and the optionality at Apex for direct-shipping germanium and gallium ore.

Scorpio Gold CEO Zayn Kalyan joins MSD's Ian Wagner to discuss new drill results from the Manhattan Gold District in Nevada, including a standout intercept from the Zanzibar Trend grading 10.4 grams per tonne gold over 5.7 meters, with an uncapped interval that would calculate above 43 grams. Kalyan explains how Zanzibar could add near-surface ounces beside the existing resource pit, while drilling continues at Black Mammoth, Gold Wedge Deep, and the Gap Zone. Scorpio is also advancing toward a potential NASDAQ listing.

Great Pacific Gold CEO Greg McCunn joins MSD's Ian Wagner to discuss new drilling at the Kavasuki target within the Wild Dog project in Papua New Guinea. McCunn explains how Kavasuki may represent a third high-grade shoot along the broader Wild Dog structural corridor, with drilling showing broad near-surface mineralization and a low-grade halo around higher-grade veining. The company is now testing below a fault with hole seven, while planning step-outs and weighing a broader 18-month drill strategy backed by roughly C$26 million in treasury.

MSD's Ian Wagner speaks with Precipitate Gold CEO Jeff Wilson about the company's current drill program at Pueblo Grande in the Dominican Republic, located beside Barrick's Pueblo Viejo mine. Wilson explains how a previously undrilled IP chargeability anomaly emerged after Barrick returned the project, and why drilling through a hard lithocap could test for gold and copper mineralization beneath. The conversation also covers planned drilling at the flagship Juan de Herrera project, including Ginger Ridge, GoldQuest's nearby discoveries, Dominican exploration rules, and Precipitate's recent share price move.